ETF Holdings Breakdown of FLGT

News associated with FLGT

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 5,986 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 13.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,654 shares of the company’s stock after […] - 2025-06-11 07:36:52

Two Sigma Investments LP Reduces Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Two Sigma Investments LP cut its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 3.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 80,082 shares of the company’s stock after selling 2,749 shares during the period. Two Sigma Investments LP’s […] - 2025-06-04 08:08:51

Squarepoint Ops LLC Grows Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Squarepoint Ops LLC boosted its position in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 178.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 41,608 shares of the company’s stock after buying an additional 26,659 shares during the quarter. Squarepoint Ops LLC owned […] - 2025-06-03 08:04:50

State of Wyoming Takes Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)

State of Wyoming bought a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,109 shares of the company’s stock, valued at approximately $57,000. Several other hedge funds and other institutional investors […] - 2025-05-29 07:47:02

Quantinno Capital Management LP Makes New Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Quantinno Capital Management LP acquired a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund acquired 13,079 shares of the company’s stock, valued at approximately $242,000. Several other large investors have also recently added to or reduced their stakes in the company. Millennium […] - 2025-05-27 07:56:53

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $987,000 Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 53,413 shares of the company’s stock after selling 2,800 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Fulgent Genetics were […] - 2025-05-26 07:43:01

Deutsche Bank AG Has $2.43 Million Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Deutsche Bank AG raised its position in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 6.1% during the fourth quarter, Holdings Channel reports. The firm owned 131,430 shares of the company’s stock after purchasing an additional 7,532 shares during the period. Deutsche Bank AG’s holdings in Fulgent Genetics were worth $2,428,000 at the end of […] - 2025-05-22 08:36:54

Balyasny Asset Management L.P. Buys Shares of 26,313 Fulgent Genetics, Inc. (NASDAQ:FLGT)

Balyasny Asset Management L.P. bought a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 26,313 shares of the company’s stock, valued at approximately $486,000. Balyasny Asset Management L.P. owned 0.09% of […] - 2025-05-16 08:50:59

Comparing Fulgent Genetics (NASDAQ:FLGT) and Grail (NASDAQ:GRAL)

Fulgent Genetics (NASDAQ:FLGT – Get Free Report) and Grail (NASDAQ:GRAL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations. Institutional & Insider Ownership 48.1% of Fulgent Genetics […] - 2025-05-12 05:54:58

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP reduced its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,045,815 shares of the company’s stock after selling 60,579 shares during the period. Dimensional Fund Advisors LP’s holdings in Fulgent Genetics were worth $19,316,000 as of its most recent […] - 2025-05-08 07:50:45

Barclays PLC Raises Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Barclays PLC boosted its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 3.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 180,397 shares of the company’s stock after acquiring an additional 5,542 shares during the quarter. Barclays PLC’s holdings in Fulgent Genetics were worth $3,332,000 as of its most […] - 2025-04-29 08:18:59

Federated Hermes Inc. Buys 1,774 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)

Federated Hermes Inc. lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 4.4% in the fourth quarter, HoldingsChannel reports. The fund owned 41,882 shares of the company’s stock after acquiring an additional 1,774 shares during the period. Federated Hermes Inc.’s holdings in Fulgent Genetics were worth $774,000 as of its […] - 2025-04-16 08:13:02

Piper Sandler Has Lowered Expectations for Fulgent Genetics (NASDAQ:FLGT) Stock Price

Fulgent Genetics (NASDAQ:FLGT – Get Free Report) had its price target cut by equities researchers at Piper Sandler from $22.00 to $16.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s price objective suggests a potential downside of 3.90% from the stock’s current price. Separately, […] - 2025-03-06 07:27:14

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund cut its holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 12.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,609 shares of the company’s stock after selling 1,324 shares during the quarter. Illinois Municipal Retirement […] - 2025-03-05 10:01:50

SG Americas Securities LLC Cuts Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)

SG Americas Securities LLC cut its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 28.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 12,518 shares of the company’s stock after selling 4,934 shares during the quarter. SG Americas Securities LLC’s holdings in Fulgent Genetics were worth $231,000 as of its most […] - 2025-02-07 08:25:42

Exchange Traded Concepts LLC Has $652,000 Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT)

Exchange Traded Concepts LLC increased its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,324 shares of the company’s stock after acquiring an additional 1,689 shares […] - 2025-01-30 08:53:06

FLGT institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	13,507	USD 264,737 0.2%
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	26,958	USD 528,377
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,584	USD 31,046
Total =		42,049	USD 824,160

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer